Transduction of Bone-Marrow-Derived Mesenchymal Stem Cells by Using Lentivirus Vectors Pseudotyped with Modified RD114 Envelope Glycoproteins

Journal of Virology

Volumn 78, Issue 3, 2004, Pages 1219-1229

  Zhang, Xian Yang ^a   La Russa, Vincent F ^b   Reiser, Jakob ^a,c  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN; LENTIVIRUS VECTOR; RD114 GLYCOPROTEIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ARTICLE; BONE MARROW CELL; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MESENCHYME CELL; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MODIFICATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL; TRANSGENE; VESICULAR STOMATITIS VIRUS; VIRUS PARTICLE; VIRUS TYPING;

ANIMALS; BONE MARROW; CATS; CELL LINE; CELLS, CULTURED; FLOW CYTOMETRY; GAMMARETROVIRUS; GENETIC VECTORS; HIV-1; HUMANS; LENTIVIRUS; MEMBRANE GLYCOPROTEINS; MESENCHYMAL STEM CELLS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; STROMAL CELLS; TRANSDUCTION, GENETIC; TRANSGENES; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 0347003599     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.3.1219-1229.2004     Document Type: Article

References (74)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Allay, J. A., J. E. Dennis, S. E. Haynesworth, M. K. Majumdar, D. W. Clapp, L. D. Shultz, A. 1. Caplan, and S. L. Gerson. 1997. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum. Gene Ther. 8:1417-1427.
3. Bartholomew, A., S. Patil, A. Mackay, M. Nelson, D. Buyaner, W. Hardy, J. Mosca, C. Sturgeon, M. Siatskas, N. Mahmud, K. Ferrer, R. Deans, A. Moseley, R. Hoffman, and S. M. Devine. 2001. Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum. Gene Ther. 12:1527-1541.
4. Baxter, M. A., R. F. Wynn, J. A. Deakin, I. Bellantuono, K. G. Edington, A. Cooper, G. T. Besley, H. J. Church, J. E. Wraith, T. F. Carr, and L. J. Fairbairn. 2002. Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type I. Blood 99:1857-1859.
5. Beyer, W. R., M. Westphal, W. Ostertag, and D. von Laer. 2002. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J. Virol. 76:1488-1495.
6. Blanco, P., M. Riminucci, S. Gronthos, and P. G. Robey. 2001. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180-192.
7. Bolotin, E., M. Smogorzewska, S. Smith, M. Widmer, and K. Weinberg. 1996. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 88:1887-1894.
8. Boshart, M., F. Weber, G. Jahn, K. Dorsch-Hasler, B. Fleckenstein, and W. Schaffner. 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521-530.
9. Castro-Malaspina, H., R. E. Gay, G. Resnick, N. Kapoor, P. Meyers, D. Chiarieri, S. McKenzie, H. E. Broxmeyer, and M. A. Moore. 1980. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56:289-301.
10. Chan, S. Y., R. F. Speck, M. C. Ma, and M. A. Goldsmith. 2000. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J. Virol. 74:4933-4937.
11. Cheng, L., C. Du, D. Murray, X. Tong, Y. A. Zhang, B. P. Chen, and R. G. Hawley. 1997. A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells. Gene Ther. 4: 1013-1022.
12. Cherington, V., G. G. Chiang, C. A. McGrath, A. Gaffney, T. Galanopoulos, W. Merrill, C. B. Bizinkauskas, M. Hansen, J. Sobolewski, P. H. Levine, J. S. Greenberger, and D. R. Hurwitz. 1998. Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs after reinfusion. Hum. Gene Ther. 9:1397-1407.
13. Chiang, G. G., H. L. Rubin, V. Cherington, T. Wang, J. Sobolewski, C. A. McGrath, A. Gaffney, S. Emami, N. Sarver, P. H. Levine, J. S. Greenberger, and D. R. Hurwitz. 1999. Bone marrow stromal cell-mediated gene therapy for hemophilia A: in vitro expression of human factor VIII with high biological activity requires the inclusion of the protcolytic site at amino acid 1648. Hum. Gene Ther. 10:61-76.
14. Choi, J. K., N. Hoang, A. M. Vilardi, P. Conrad, S. G. Emerson, and A. M. Gewirtz. 2001. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hemalopoictic cells . Stem Cells 19:236-246.
15. Christodoulopoulos, I., and P. M. Cannon. 2001. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors. J. Virol. 75: 4129-4138.
16. Chuah, M. K., H. Brems, V. Vanslembrouck, D. Collen, and T. Vandendriessche. 1998. Bone marrow stromal cells as targets for gene therapy of hemophilia A. Hum. Gene Ther. 9:353-365.
17. Chuah, M. K., A. Van Damme, H. Zwinnen, I. Goovaerts, V. Vanslembrouck, D. Collen, and T. Vandendriessche. 2000. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice. Hum. Gene Ther. 11:729-738.
18. Conget, P. A., and J. J. Minguell. 2000. Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. Exp. Hematol. 28:382-390.
19. Cosset, F. L., Y. Takeuchi, J. L. Battini, R. A. Weiss, and M. K. Collins. 1995. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:7430-7436.
20. Deans, R. J., and A. B. Moseley. 2000. Mesenchymal stem cells: biology and potential clinical uses. Exp. Hematol. 28:875-SS4.
21. Ding, L., S. Lu, R. Batchu, R. S. Iii, and N. Munshi. 1999. Bone marrow stromal cells as a vehicle for gene transfer. Gene Ther. 6:1611-1616.
22. DuBridge, R. B., P. Tang, H. C. Hsia, P. M. Leong, J. H. Miller, and M. P. Calos. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
23. el Kharroubi, A., and M. A. Martin. 1996. cis-acting sequences located downstream of the human immunodeficiency virus type I promoter affect its chromatin structure and transcriptional activity. Mol. Cell. Biol. 16:2958-2966.
24. Friedenstein, A. J., J. F. Gorskaja, and N. N. Kulagina. 1976. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 4:267-274.
25. Frolova-Jones, E. A., A. Ensser, A. J. Stevenson, S. E. Kinsey, and D. M. Meredith. 2000. Stable marker gene transfer into human bone marrow stromal cells and their progenitors using novel herpesvirus saimiri-based vectors. J. Hematother. Stem Cell Res. 9:573-581.
26. Gao, Z., J. Golob, V. M. Tanavde, C. I. Civin, R. G. Hawley, and L. Cheng. 2001. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector. Stem Cells 19:247-259.
27. Gerson, S. L. 1999. Mesenchymal stem cells: no longer second class marrow citizens. Nat. Med. 5:262-264.
28. Gordon, E. M., M. Skotzko, R. K. Kundu, B. Han, J. Andrades, M. Nimni, W. F. Anderson, and F. L. Hall. 1997. Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-betal-von Willebrand's factor fusion protein for retrovirus-mediatcd delivery of coagulation factor IX. Hum. Gene Ther. 8:1385-1394.
29. Gysin, R., J. E. Wergedal, M. H. Sheng, Y. Kasukawa, N. Miyakoshi, S. T. Chen, H. Peng, K. H. Lau, S. Mohan, and D. J. Baylink. 2002. Ex vivo gene therapy with stromal cells transduced with a rctroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats. Gene Ther. 9:991-999.
30. Hanawa, H., P. F. Kelly, A. C. Nathwani, D. A. Persons, J. A. Vandergriff, P. Hargrove, E. F. Vanin, and A. W. Nienhuis. 2002. Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol. Ther. 5:242-251.
31. Hawley, R. G., F. H. Lieu, A. Z. Fong, and T. S. Hawley. 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:136-138.
32. Hurwitz, D. R., M. Kirchgesser, W. Merrill, T. Galanopoulos, C. A. McGrath, S. Emami, M. Hansen, V. Cherington, J. M. Appel, C. B. Bizinkauskas, H. H. Brackmann, P. H. Levine, and J. S. Greenberger. 1997. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hum. Gene Ther. 8:137-156.
33. Ikeda, Y., Y. Takeuchi, F. Martin, F. L. Cosset, K. Mitrophanous, and M. Collins. 2003. Continuous high-titer HIV-I vector production. Nat. Biotechnol. 21:569-572.
34. Jaalouk, D. E., N. Eliopoulos, C. Couture, S. Mader, and J. Galipeau. 2000. Glucocorticoid-inducible retrovector for regulated transgene expression in genctically engineered bone marrow stromal cells. Hum. Gene Ther. II: 1837-1849.
35. Julias, J. G., A. L. Ferris, P. L. Boyer, and S. H. Hughes. 2001. Replication of phenotypically mixed human immunodeficiency virus type I virions containing catalytically active and catalytically inactive reverse transcriptase. J. Virol. 75:6537-6546.
36. Kobinger, G. P., D. J. Weiner, Q. C. Yu, and J. M. Wilson. 2001. Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 19:225-230.
37. Kowolik, C. M., and J. K. Yee. 2002. Preferential transduction of human hepatocytes with lentiviral vectors pseudotyped by Sendai virus F protein. Mol. Ther. 5:762-769.
38. Krebsbach, P. H., K. Zhang, A. K. Malik, and K. Kurachi. 2003. Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor IX model. J. Gene Med. 5:11-17.
39. Kumar, M., B. P. Bradow, and J. Zimmerberg. 2003. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64. Hum. Gene Ther. 14:67-77.
40. Landau, N. R., and D. R. Littman. 1992. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66:5110-5113.
41. Landau, N. R., K. A. Page, and D. R. Littman. 1991. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J. Virol. 65:162-169.
42. Lee, K., M. K. Majumdar, D. Buyaner, J. K. Hendricks, M. F. Pittenger, and J. D. Mosca. 2001. Human mesenchymal stem cells maintain transgene expression during expansion and differentiation. Mol. Ther. 3:857-866.
43. Lewis, B. C., N. Chinnasamy, R. A. Morgan, and H. E. Varmus. 2001. Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector. J. Virol. 75:9339-9344.
44. Marino, M. P., M. J. Luce, and J. Reiser. 2003. Small-to high-scale production of lentivirus vectors. Methods Mol. Biol. 229:43-55.
45. Martino, S., C. Cavalieri, C. Emiliani, D. Dolcetta, M. G. Cusella De Angelis, V. Chigorno, G. M. Severini, K. Sandhoff, C. Bordignon, S. Sonnino, and A. Orlacchio. 2002. Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model. Neurochem. Res. 27:793-800.
46. Marx, J. C., J. A. Allay, D. A. Persons, S. A. Nooner, P. W. Hargrove, P. F. Kelly, E. F. Vanin, and E. M. Horwitz. 1999. High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells. Hum. Gene Ther. 10:1163-1173.
47. Matzner, U., K. Harzer, R. D. Learish, J. A. Barranger, and V. Gieselmann. 2000. Long-term expression and transfer of arylsulfatasc A into brain of arylsulfatase A-deficient mice transplanted with bone marrow expressing the arylsulfatase A cDNA from a retroviral vector. Gene Ther. 7:1250-1257.
48. Matzner, U., F. Schestag, D. Hartmann, R. Lullmann-Rauch, R. D'Hooge, P. P. De Deyn, and V. Gieselmann. 2001. Bone marrow stem cell gene therapy of arylsulfatase A-deficient mice, using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type cells. Hum. Gene Ther. 12:1021-1033.
49. Min, Y. H., G. X. Li, J. H. Jang, H. C. Suh, J. S. Kim, J. W. Cheong, S. T. Lee, J. S. Hahn, and Y. W. Ko. 2002. Long-term bone marrow culture-derived stromal fibroblasts as a potential target for gene therapy in acute myelogenous leukemia. Leukoc. Res. 26:369-376.
50. Minguell, J. J., A. Erices, and P. Conget. 2001. Mesenchymal stem cells. Exp. Biol. Med. 226:507-520.
51. Mochizuki, H., J. P. Schwartz, K. Tanaka, R. O. Brady, and J. Reiser. 1998. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J. Virol. 72:8873-8883.
52. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
53. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199.
54. Nolta, J. A., M. B. Hanley, and D. B. Kohn. 1994. Sustained human hematopoiesis immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood 83:3041-3051.
55. Padgett, K. A., and J. A. Sorge. 1996. Creating seamless junctions independent of restriction sites in PCR cloning. Gene 168:31-35.
56. Pereira, R. F., K. W. Halford, M. D. O'Hara, D. B. Leeper, B. P. Sokolov, M. D. Pollard, O. Bagasra, and D. J. Prockop. 1995. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone,. cartilage, and lung in irradiated mice. Proc. Natl. Acad. Sci. USA 92:4857-4861.
57. Pittenger, M. F., A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas, J. D. Mosca, M. A. Moorman, D. W. Simonetti, S. Craig, and D. R. Marshak. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
58. Porter, C. D., M. K. Collins, C. S. Tailor, M. H. Parkar, F. L. Cosset, R. A. Weiss, and Y. Takeuchi. 1996. Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors. Hum. Gene Ther. 7:913-919.
59. Reiser, J. 2000. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther. 7:910-913.
60. Reiser, J., G. Harmison, S. Kluepfel-Stahl, R. O. Brady, S. Karlsson, and M. Schubert. 1996. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. USA 93:15266-15271.
61. Reiser, J., Z. Lai, X. Y. Zhang, and R. O. Brady. 2000. Development of multigene and regulated lentivirus vectors. J. Virol. 74: 10589-10599.
62. Sanchez-Ramos, J., S. Song, F. Cardozo-Pelaez, C. Hazzi, T. Stedeford, A. Willing, T. B. Freeman, S. Saporta, W. Janssen, N. Patel, D. R. Cooper, and P. R. Sanberg. 2000. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol. 164:247-256.
63. + cells derived from human and nonhuman primates. Blood 100:823-832.
64. Schwarz, E. J., G. M. Alexander, D. J. Prockop, and S. A. Azizi. 1999. Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. Hum. Gene Ther. 10:2539-2549.
65. Schwarz, E. J., R. L. Reger, G. M. Alexander, R. Class, S. A. Azizi, and D. J. Prockop. 2001. Rat marrow stromal cells rapidly transduced with a self-inactivating retrovirus synthesize L-DOPA in vitro. Gene Ther. 8:1214-1223.
66. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffiths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
67. Southgate, C., M. L. Zapp, and M. R. Green. 1990. Activation of transcription by HIV-I Tat protein tethered to nascent RNA through another protein. Nature 345:640-642.
68. Stitz, J., C. J. Buchholz, M. Engelstadter, W. Uckert, U. Bloemer, I. Schmitt, and K. Cichutek. 2000. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10AI. Virology 273:16-20.
69. Sutton, R. E., and D. R. Littman. 1996. Broad host range of human T-cell leukemia virus type I demonstrated with an improved pseudotyping system. J. Virol. 70:7322-7326.
70. Takada, T., K. lida, T. Awaji, K. Itoh, R. Takahashi, A. Shibui, K. Yoshida, S. Sugano, and G. Tsujimoto. 1997. Selective production of transgenic mice using green fluorescent proteinas a marker. Nat. Biotechnol. 15: 458-461.
71. Takeuchi, Y., F. L. Cosset, P. J. Lachmann, H. Okada, R. A. Weiss, and M. K. Collins. 1994. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68: 8001-8007.
72. Tsuda, H., T. Wada, Y. Ito, H. Uchida, H. Dehari, K. Nakamura, K. Sasaki, M. Kobune, T. Yamashita, and H. Hamada. 2003. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol. Ther. 7:354-365.
73. Zhang, X. Y., V. F. La Russa, L. Bao, J. Kolls, P. Schwarzenberger, and J. Reiser. 2002. Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. Mol. Ther. 5:555-565.
74. Zhang, X. Y., V. F. La Russa, and J. Reiser. 2003. Mesenchymal stem cells. Methods Mol. Biol. 229:131-140.